Jan 25 (Reuters) - European Medicines Agency:
* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.1 USD | -0.87% | +9.75% | +21.74% |
05-07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
05-06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
Jan 25 (Reuters) - European Medicines Agency:
* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.17% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B | |
+21.07% | 11.81B |